Related Experiment Video
Updated: Dec 24, 2025
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
2.0K
[New HIV-1 protease inhibitors in development]
Kazuhisa Yoshimura1, Kenji Maeda
1Division of Clinical Retrovirology and Infections Diseases, Center for AIDS Research, Kumamoto University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 24, 2002
Summary
Protease inhibitors are crucial for blocking HIV-1 maturation. New protease inhibitor drugs are being developed to improve effectiveness and patient outcomes in HIV treatment.
Area of Science:
- Virology
- Pharmacology
- Drug Development
Context:
- HIV-1 protease is essential for viral maturation.
- Protease inhibitors target this critical enzyme.
- Current research focuses on developing improved inhibitors.
Purpose:
- To summarize the role of protease inhibitors in HIV-1 therapy.
- To highlight ongoing drug development efforts.
- To discuss the potential of new protease inhibitors.
Summary:
- Protease inhibitors function by blocking the HIV-1 protease enzyme, preventing the assembly of mature, infectious viral particles.
- Several protease inhibitors are under investigation, including Atazanavir, GW433908, L-756,423, Mozenavir (DMP-450), and Tipranavir.
- The development of novel protease inhibitors aims for enhanced pharmacokinetic and resistance profiles compared to existing treatments.
Impact:
- Successful development of new protease inhibitors could lead to significant clinical advancements in managing HIV.
- Improved drug profiles may offer better treatment options for patients requiring effective HIV therapies.
Related Concept Videos
01:10Retrovirus Life Cycles
49.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.0K
01:23Dipeptidyl Peptidase 4 Inhibitors
485
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
485